Summary
Latest filing:
Samsara BioCapital GP, LLC files SEC Form 4 reports at vTv Therapeutics Inc. (VTVT). 2 SEC Form 4 filings on record, most recently on 6 December 2024. Most recent open-market trade: bought $55K of NGNE on 27 November 2024. Lifetime open-market purchases: $1.26M.
Recent transactions
5The latest 5 SEC Form 4 transactions reported by Samsara BioCapital GP, LLC.
Trading pattern
InsiderAlpha's records for Samsara BioCapital GP, LLC go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. The typical open-market purchase is $315K (4 buys totaling $1.26M). The largest single buy on record is $517K of NGNE in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Samsara BioCapital GP, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine Mikail Cvijic - $900K in NGNE purchases and sales in the last 12 months
- Stuart Cobb - $141K in NGNE purchases and sales in the last 12 months
- Rachel McMinn - $74K in NGNE purchases and sales in the last 12 months
- Julie Jordan - $18K in NGNE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Samsara BioCapital GP, LLC?
Samsara BioCapital GP, LLC is a corporate entity of vTv Therapeutics Inc. (VTVT). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Samsara BioCapital GP, LLC last file a Form 4?
The most recent primary Form 4 on record is dated 6 December 2024, one of 2 filings going back to 2024.
Has Samsara BioCapital GP, LLC been buying or selling stock?
Recorded transactions: 4 open-market purchases ($1.26M) and 0 open-market sales across all tracked filings.